The Management of Co-Morbidities in Patients with Heart Failure – Hypertension
International Cardiovascular Forum Journal · 2017
DOI: 10.17987/icfj.v10i0.452 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Cardiovascular Forum Journal, 2017. Verfasst von Andrew J Stewart Coats und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. Foremost of these in terms of frequency and its relevance to the aetiology of HF, especially HFpEF is hypertension. In this artcile we will review what the recent guidelines say about the management of hypertension in the setting of HF, both HFrEF and HFpEF and expand on some of the practical advice.
Zitieren
APA
Coats, A. J. S., Rosano, G. M., & Lopatin, Y. M. (2017). The Management of Co-Morbidities in Patients with Heart Failure – Hypertension. International Cardiovascular Forum Journal. https://doi.org/10.17987/icfj.v10i0.452
Vancouver
Coats AJS, Rosano GM, Lopatin YM. The Management of Co-Morbidities in Patients with Heart Failure – Hypertension. International Cardiovascular Forum Journal. 2017. doi:10.17987/icfj.v10i0.452
BibTeX
@article{Coats2017,
author = {Coats, Andrew J Stewart and Rosano, Giuseppe MC and Lopatin, Yuri M.},
title = {The Management of Co-Morbidities in Patients with Heart Failure – Hypertension},
journal = {International Cardiovascular Forum Journal},
year = {2017},
doi = {10.17987/icfj.v10i0.452}
}
EUVIMED